Table 2.
HCC (n = 70) | CH (n = 30) | Control (n = 33) | ||
Age, mean (range) | 57.32 (20-74)a | 47.70 (43-60)a | 51.09 (31-75) | |
Gender (male/female) | 67/3 | 21/9 | 33/0 | |
AFP | Mean (range) | 9547.54 (15-117032)ac | 11.02 (1-30)a | 7.45 (4-10) |
Median | 1481.5ac | 8.9a | 7.9 | |
Total bilirubin | Mean (range) | 2.66 (0.8-8.6)a | 4.73 (0.6-114.0) | 0.60 (0.3-1.0) |
Median | 2.0a | 1 | 0.6 | |
ALT | Mean (range) | 71.39 (17-189)a | 54.23 (10-200)a | 24.91 (16-37) |
Median | 57.5a | 34.5a | 25 | |
AST | Mean (range) | 122.94 (35-530)ac | 54.47 (12-140)a | 28.45 (17-39) |
Median | 88.5ac | 39.5a | 28 | |
Creatinine | Mean (range) | 1.09 (0.4-2.0)ac | 0.84 (0.5-1.1) | 0.81 (0.4-1.4) |
Median | 1.0ac | 0.9 | 0.8 | |
Alkaline phosphatase | Mean (range) | 240.50 (76-580)ac | 138.90 (80-220)a | 44.39 (15-71) |
Median | 218.5ac | 132.5a | 44 |
P < 0.05 vs controls;
P < 0.05 vs CH. AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CH: Chronic hepatitis; HCC: Hepatocellular carcinoma.